日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study

[¹⁸F]FDG PET 和代谢变化对接受再次 PRRT 治疗的晚期转移性神经内分泌肿瘤患者的预后意义:一项多中心 10 年生存率 WARMTH 研究的最终结果

Santo, Giulia; Rodrigues, Margarida; Paez, Diana; Morozova, Olga; Kabasakal, Levent; Kairemo, Kalevi; Grana, Chiara Maria; Baum, Richard P; di Santo, Gianpaolo; Virgolini, Irene J

Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years

动脉内肽受体放射性核素治疗(IA-PRRT)治疗表达生长抑素受体(SSTR)的神经内分泌肿瘤患者:长达13年的短期和长期安全性和有效性

Zhang, Jingjing; Mensel, Birger; Baum, Richard P

Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3

超越TOC和TATE的Alpha疗法——SSTR2拮抗剂DOTA-LM3的生产、质量控制和人体试验结果

Greifenstein, Lukas; Martin, Marcel; Stephan, Sarah; Eismant, Aleksandr; Kramer, Carsten S; Landvogt, Christian; Mueller, Corinna; Rösch, Frank; Baum, Richard P

Systematic review and meta-analysis of the efficacy and safety of [(177)Lu]Lu-edotreotide ([(177)Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors

对[(177)Lu]Lu-edotreotide ([(177)Lu]Lu-DOTATOC)治疗神经内分泌肿瘤的疗效和安全性进行系统评价和荟萃分析

Baum, Richard P; Fricke, Julia G; Ruhwedel, Tristan; Amthauer, Holger; Azorin-Vega, Erika Patricia; Hörsch, Dieter; Laudicella, Riccardo; Maheshwari, Vikalp; Walter, Martin A; Polack, Berna Degirmenci; Spiegl, Simon F; Nicolas, Guillaume P

First-in-human study of an optimized, potential kit-type, SSTR antagonist (68)Ga-DATA(5m)-LM4 in patients with metastatic neuroendocrine tumors

首次人体研究:优化的潜在试剂盒型SSTR拮抗剂(68)Ga-DATA(5m)-LM4在转移性神经内分泌肿瘤患者中的应用

Zhang, Jingjing; Greifenstein, Lukas; Jakobsson, Vivianne; Zan, Elcin; Klega, Andre; Rösch, Frank; Landvogt, Christian; Mueller, Corinna; Baum, Richard P

Targeted radioligand therapy: physics and biology, internal dosimetry and other practical aspects during (177)Lu/(225)Ac treatment in neuroendocrine tumors and metastatic prostate cancer

靶向放射性配体治疗:神经内分泌肿瘤和转移性前列腺癌中 (177)Lu/(225)Ac 治疗的物理学和生物学、内剂量学及其他实际问题

Dadgar, Habibollah; Pashazadeh, Ali; Norouzbeigi, Nasim; Assadi, Majid; Al-Balooshi, Batool; Baum, Richard P; Al-Ibraheem, Akram; Haidar, Mohamad; Beheshti, Mohsen; Geramifar, Parham; Vali, Reza; Mohammadi, Seyed; Dash, Swagat; Malasani, Vindhya; Cimini, Andrea; Ricci, Maria; Esmail, Abdulredha A; Murad, Sarah; Marafi, Fahad; Treglia, Giorgio; Khalaf, Aysar Najeh; Anwar, Farah M; Usmani, Sharjeel; Omar, Yehia; Muhsin, Haider; Tyurin, Igore E; Zakhary, Andrew; Al-Sebaie, Sahar; Cortes, Danny Mena; AlHashim, Maryam; Arabi, Hossein; Zaidi, Habib

Cost-utility analysis of (177)Lu-PSMA-617 radioligand therapy in second-line and third-line treatment for metastatic castration-resistant prostate cancer (mCRPC) in Germany

德国转移性去势抵抗性前列腺癌(mCRPC)二线和三线治疗中(177)Lu-PSMA-617放射性配体疗法的成本效益分析

Brinkmann, Carolin; Baum, Richard P; Stargardt, Tom

Correction to: Guiding principles on the education and practice of theranostics

更正:治疗诊断学教育与实践指导原则

Pascual, Thomas N B; Paez, Diana; Iagaru, Andrei; Gnanasegaran, Gopi; Lee, Sze Ting; Sathekge, Mike; Buatti, John M; Giammarile, Francesco; Al-Ibraheem, Akram; Pardo, Manuela Arevalo; Baum, Richard P; De Bari, Berardino; Ben-Haim, Simona; Blay, Jean-Yves; Brink, Anita; Estrada-Lobato, Enrique; Fanti, Stefano; Golubic, Anja Tea; Hatazawa, Jun; Israel, Ora; Kiess, Ana; Knoll, Peter; Kunikowska, Jolanta; Louw, Lizette; Mariani, Giuliano; Mirzaei, Siroos; Orellana, Pilar; Prior, John O; Urbain, Jean-Luc; Vichare, Shrikant; Vinjamuri, Sobhan; Virgolini, Irene; Scott, Andrew M

The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy

PANEN列线图:为接受肽受体放射性核素治疗的转移性胰腺神经内分泌肿瘤患者提供临床决策支持

Singh, Aviral; Sanduleanu, Sebastian; Kulkarni, Harshad R; Langbein, Thomas; Lambin, Philippe; Baum, Richard P

The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand Therapy

放射性配体疗法对SARS-CoV-2免疫原性的影响——一项接受PSMA放射性配体疗法的转移性前列腺癌患者的回顾性单臂队列研究

Kramer, Carsten S; Eismant, Aleksandr; Mishra, Aditi; Müller, Corinna; Landvogt, Christian; Baum, Richard P